Software Healthcare Sector

InMed Pharmaceuticals

Market Cap: US$6.4m

A clinical stage pharmaceutical company, develops a pipeline of prescription-based products in the United States.

America Great Health

Market Cap: US$6.3m

Operates as a biotechnology company in the United States.

NuCana

Market Cap: US$6.3m

A clinical-stage biopharmaceutical company, engages in the development of medicines to treat patients with cancer in the United States.

Careteq

Market Cap: AU$8.8m

Engages in medication management and clinical governance for health, aged, and home care sectors in Australia.

Enveric Biosciences

Market Cap: US$6.3m

A biotechnology company, focuses on the development of small molecule neuroplastogenic therapeutics that address unmet needs in psychiatric and neurological disorders in the United States.

Reviva Pharmaceuticals Holdings

Market Cap: US$6.3m

A biopharmaceutical company, discovers, develops, and commercializes next-generation therapeutics for diseases targeting unmet medical needs in the areas of central nervous system, respiratory, inflammatory, and cardiometabolic diseases.

Liminatus Pharma

Market Cap: US$6.3m

A pre-clinical stage biopharmaceutical company, engages in the development of cancer therapies in the United States.

Glow Lifetech

Market Cap: CA$8.7m

An ingredient technology company, focuses on producing nutraceutical and cannabinoid-based products.

Cambridge Nutritional Sciences

Market Cap: UK£4.5m

Develops, manufactures, and distributes medical diagnostics products for the food sensitivity testing market.

Epsilon Healthcare

Market Cap: AU$8.6m

Engages in the healthcare business in Australia.

CYduct Diagnostics

Market Cap: US$6.1m

A healthcare company, develops, produces, and markets medical devices for the assessment, identification, diagnosis and treatment of breast cancer.

Meihua International Medical Technologies

Market Cap: US$6.1m

Meihua International Medical Technologies Co., Ltd.

Processa Pharmaceuticals

Market Cap: US$6.1m

A clinical-stage biopharmaceutical company, develops cancer therapy drugs to improve the safety and efficacy of cancer treatment in the United States.

Innovative Holdings Alliance

Market Cap: US$6.0m

A medical technology holding company, offers personal care products in North America.

Gelteq

Market Cap: US$5.9m

Focuses on developing and commercializing white label gel-based delivery solutions for humans and animals in the United States of America, China and Australia.

Avricore Health

Market Cap: CA$8.2m

Engages in the health data and point-of-care technologies businesses in Canada and the United Kingdom.

Firebrick Pharma

Market Cap: AU$8.3m

Engages in the development and commercialization of povidone-iodine (PVP-I) products under the Nasodine brand in Asia, North America, Europe, and internationally.

Ensysce Biosciences

Market Cap: US$5.9m

A clinical-stage pharmaceutical company, develops prescription drugs for severe pain relief in opioid misuse, abuse, and overdose in the United States.

Apptly Health Technologies

Market Cap: CA$8.0m

Operates a digital healthcare platform in global markets.

Orgenesis

Market Cap: US$5.8m

A biotech company, focuses on cell and gene therapies in the United States.

Bio Green Med Solution

Market Cap: US$5.8m

Engages in the distributing, trading, and installation of protective and fire safety materials and equipment, and fire protection and prevention systems.

Cardio Diagnostics Holdings

Market Cap: US$5.7m

Develops and commercializes epigenetics-based clinical tests for cardiovascular disease.

CollPlant Biotechnologies

Market Cap: US$5.7m

A regenerative and aesthetic medicine company, focuses on three-dimensional (3D) bioprinting of tissues and organs, and medical aesthetics in the United States, Canada, Israel, Europe, and internationally.

Pulmatrix

Market Cap: US$5.7m

A biopharmaceutical company, focused on development of novel inhaled therapeutic products to prevent and treat migraine and respiratory diseases with unmet medical needs in the United States.

Nuformix

Market Cap: UK£4.1m

Together with its subsidiary, Nuformix Technologies Limited, operates in the field of pharmaceutical development for treating fibrosis and oncology through drug repurposing in the United Kingdom.

PharmaCyte Biotech

Market Cap: US$5.6m

A biotechnology company, focused on developing and preparing to commercialize cellular therapies for cancer using live cell encapsulation technology in the United States.

Cadrenal Therapeutics

Market Cap: US$5.6m

Operates as a late-stage biopharmaceutical company that develops novel therapies for life-threatening immune and thrombotic conditions.

Theracryf

Market Cap: UK£4.1m

A clinical stage therapeutics company, engages in the development of therapeutics for oncology and behavioural brain disorders.

Vivos Therapeutics

Market Cap: US$5.6m

Operates as a medical technology and healthcare services company that develops and commercializes treatment modalities for patients with dentofacial abnormalities, obstructive sleep apnea (OSA), and snoring in adults.

Yi Po International Holding

Market Cap: US$5.6m

Operates as a vertically integrated cannabis company in Canada and the United States.

PD-Rx Pharmaceuticals

Market Cap: US$5.5m

Engages in the repackaging and distribution of prepackaged pharmaceutical products for the healthcare industry in the United States.

Hepion Pharmaceuticals

Market Cap: US$5.5m

A biopharmaceutical company, focuses on the development of treatment for hepatocellular carcinoma (HCC), metabolic liver diseases, and chronic liver diseases in the United States.

Kairos Pharma

Market Cap: US$5.5m

A clinical-stage biopharmaceutical company, develops immunotherapy and cell therapies for the treatment of cancer.

Panacea Life Sciences Holdings

Market Cap: US$5.5m

Operates as a holding company, researchers, develops, manufactures, produces, and distributes cannabinoids, mushrooms, kratom, and other natural, plant-based ingredients and products for humans and animals.

CordovaCann

Market Cap: US$5.5m

Engages in the provision of services and investment capital to the processing, production, and retail vertical markets of the cannabis industry in Canada and United States.

cbdMD

Market Cap: US$5.5m

Produces and distributes various cannabidiol (CBD) products in the United States and internationally.